Abstract

Rheumatoid arthritis (RA) is a multifactorial, complex autoimmune disease that involves various genetic, environmental, and epigenetic factors. Systems biology approaches provide the means to study complex diseases by integrating different layers of biological information. Combining multiple data types can help compensate for missing or conflicting information and limit the possibility of false positives. In this work, we aim to unravel mechanisms governing the regulation of key transcription factors in RA and derive patient-specific models to gain more insights into the disease heterogeneity and the response to treatment. We first use publicly available transcriptomic datasets (peripheral blood) relative to RA and machine learning to create an RA-specific transcription factor (TF) co-regulatory network. The TF cooperativity network is subsequently enriched in signalling cascades and upstream regulators using a state-of-the-art, RA-specific molecular map. Then, the integrative network is used as a template to analyse patients’ data regarding their response to anti-TNF treatment and identify master regulators and upstream cascades affected by the treatment. Finally, we use the Boolean formalism to simulate in silico subparts of the integrated network and identify combinations and conditions that can switch on or off the identified TFs, mimicking the effects of single and combined perturbations.

Highlights

  • Rheumatoid arthritis (RA) is an inflammatory, autoimmune disease that affects the joints of the body

  • We present a framework for integrating signalling and transcriptional regulation cascades with genomic mutations, combining data-driven approaches with prior knowledge in the form of an integrative RA-specific network

  • After a series of pre-processing checks, including the sample origins, duplicates, and quality of the data using a pal Component Analysis (PCA) on the matrix expression with normalisation and variance stabilising transformation, we kept for further analysis a total of 90 samples (48 Controls and 42 RA patients)

Read more

Summary

Introduction

Rheumatoid arthritis (RA) is an inflammatory, autoimmune disease that affects the joints of the body. RA affects 0.5–1% of the world population, with women three times more susceptible to developing RA than men [1,2]. The onset of the disease is set around the fourth to fifth decade of one’s life [3] and, if left untreated, it can be debilitating for the individual. Symptoms of RA include synovial inflammation, joint stiffness and pain, cartilage destruction, and bone erosion. In early RA, leukocytes invade the synovial joints, followed by other pro-inflammatory mediators, instigating an inflammatory cascade and provoking synovitis [2]. Activated monocytes and T cells, both a source of pro-inflammatory cytokines such as TNF-a, can be found in peripheral blood [4], and many

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call